Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01446822
Other study ID # URO-OBT-01
Secondary ID
Status Completed
Phase N/A
First received October 3, 2011
Last updated March 2, 2018
Start date October 2011
Est. completion date September 2016

Study information

Verified date March 2018
Source Cantonal Hospital of St. Gallen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single-center, prospective, randomized, controlled trial comparing two established transurethral electrical resection methods of urinary bladder tumors regarding their risk of stimulating the obturator nerve.

One of the major safety issues with transurethral resection is bladder perforation as a consequence of obturator nerve stimulation followed by muscle contraction of. This is mostly a risk of resection of lateral bladder wall tumors near the course of the obturator nerve. It has been advocated that bipolar may be superior to monopolar resection, based on its different electrical properties. This is an important safety aspect for the patient.

Main study question: In patients with lateral wall urinary bladder tumors, is bipolar superior to monopolar transurethral electroresection regarding risk of stimulation of the obturator nerve without preoperative nerve block?


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date September 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- neoplasms of the lateral wall of the urinary bladder (laterally to the corresponding ostium)

- operability given based on general medical condition

- informed consent

Exclusion Criteria:

- antiplatelet drugs stopped <7days (except acetylsalicylate <= 100mg p.o. qd)

- prothrombine time <70%

- age <18 years

- patronized Patients

- pregnancy

- severe poor medical condition

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Bipolar transurethral resection of the urinary bladder (PlasmaKinetic, Gyrus, Fresenius)
Lateral wall urinary bladder tumors are resected transurethrally without obturator nerve block or relaxation under general anesthesia. If resection not possible because of adductor muscle contraction, patients undergo relaxation.
Monopolar transurethral resection of the urinary bladder (Storz GmbH &Co., Erbotom, Purisole)
Lateral wall urinary bladder tumors are resected transurethrally without obturator nerve block or relaxation under general anesthesia. If resection is not possible because of adductor muscle contraction, patients are treated by bipolar resection. If this is still not possible, they undergo relaxation.

Locations

Country Name City State
Switzerland Cantonal Hospital of St.Gallen St. Gallen

Sponsors (1)

Lead Sponsor Collaborator
Daniel Stephan Engeler

Country where clinical trial is conducted

Switzerland, 

References & Publications (1)

Gramann T, Schwab C, Zumstein V, Betschart P, Meier M, Schmid HP, Engeler DS. Transurethral resection of bladder cancer on the lateral bladder wall without obturator nerve block: extent of adductor spasms using the monopolar versus bipolar technique - a p

Outcome

Type Measure Description Time frame Safety issue
Primary Successful resection of bladder tumor Successful resection of the neoplasm without relevant stimulation of the obturator nerve and consecutive contraction of the ipsilateral adductor muscles Intraoperative
Secondary Complications Degree of severity of the complications (perforation of the bladder, intraoperative bleeding, postoperative bleeding, others) according to the Clavien-classification 3 months